πŸ“ Whitefield, Bangalore
HOD & Senior Consultant Β· Surgical Oncology
Consultation by Appointment
Home/Cancer Specialties/Hepato Biliary Pancreatic Cancer
Cancer Specialties

Hepatobiliary & Pancreatic Cancer Surgery

Surgery for liver, bile duct, gallbladder and pancreatic cancers β€” complex, high-stakes operations planned carefully around each patient’s anatomy and fitness for surgery.
Whipple Procedure
Liver Resection
Robotic Surgery
Multivisceral Surgery

How your treatment is personalised

Every treatment plan is personalised. Dr Ashwin K.R. reviews your scans, pathology and, where relevant, biomarker results with a multidisciplinary team, then recommends a sequence of treatment that fits your cancer and your health.

  • Your case is reviewed at a multidisciplinary tumour board.
  • Surgery, systemic treatment and radiotherapy are explained with their goals and side effects.
  • A second opinion is welcome, and you can bring your reports to the consultation.

Overview

Hepatobiliary & Pancreatic Cancer Surgery is one of Dr Ashwin K.R.’s core areas of practice at Aster Whitefield, Bangalore. Treatment planning combines careful staging, multidisciplinary discussion and a surgical approach chosen to balance oncological safety with quality of life.

Symptoms & When to See a Surgeon

  • Jaundice (yellowing of skin or eyes)
  • Unexplained upper abdominal or back pain
  • Unintentional weight loss or loss of appetite
  • An abnormal finding on liver or pancreatic imaging
These symptoms have many possible causes, but persistent or unexplained symptoms warrant a timely surgical oncology consultation.

Surgical Treatment Approach

  • Pancreaticoduodenectomy (Whipple procedure) and distal pancreatectomy
  • Liver resection for primary and selected secondary liver cancers
  • Robotic-assisted approaches where clinically appropriate
  • Careful pre-operative optimisation given the complexity of hepato biliary pancreatic surgery
Where relevant, this may draw on Robotic Cancer Surgery β†’ as part of an integrated treatment plan.

Why Choose Dr Ashwin K.R.

16+ years of experience, 11,000+ major cancer surgeries and a practice built on clear communication β€” every patient understands their diagnosis, options and the realistic road ahead before deciding on surgery.

Quick facts

Experience
16+ years
Hospital
Aster Whitefield
Location
Whitefield, Bangalore
Approach
Multidisciplinary

Have reports for a hepato biliary pancreatic cancer diagnosis?

Bring your pathology and imaging reports for a focused surgical opinion.

Recovery and what to bring to your consultation

  • Recovery depends on the treatment you need. Your team will explain the expected hospital stay, return to daily activities and follow-up before any treatment starts.
  • Bring your pathology and imaging reports, any blood test results, a list of current medicines, summaries of any earlier treatment, and your ID and insurance documents.

Frequently Asked Questions

1. Understanding Hepatobiliary & Pancreatic Cancer

What is hepatobiliary and pancreatic (HPB) cancer?

Hepatobiliary and pancreatic (HPB) cancer is the group of cancers that start in the liver, bile ducts, gallbladder, pancreas and ampulla of Vater, the organs that produce and deliver bile and digestive enzymes.

  • Hepato: The liver, which filters blood, stores energy and makes bile.
  • Biliary: The bile ducts and gallbladder, which store and carry bile into the intestine.
  • Pancreatic: The pancreas, which makes digestive enzymes and hormones such as insulin.
  • Why they are grouped: These organs share blood vessels and drainage channels, so their cancers need similar specialist surgical and medical expertise.

What are the different types of HPB cancer?

The main HPB cancers are pancreatic adenocarcinoma, hepatocellular carcinoma, cholangiocarcinoma, gallbladder cancer, ampullary cancer and pancreatic neuroendocrine tumors, along with cancers that spread to the liver from elsewhere.

Cancer TypeWhere It StartsKey Facts
Pancreatic ductal adenocarcinoma (PDAC)Cells lining the pancreatic ductsMost common pancreatic cancer (about 90%); often diagnosed late
Pancreatic neuroendocrine tumor (PNET)Hormone-producing cells of the pancreasUsually slower-growing; may produce hormones causing symptoms
Hepatocellular carcinoma (HCC)Main liver cells (hepatocytes)Most common primary liver cancer; often linked to cirrhosis or hepatitis
Intrahepatic cholangiocarcinomaBile ducts inside the liverOften presents as a liver mass
Perihilar cholangiocarcinoma (Klatskin tumor)Bile ducts where they leave the liverCommonly causes jaundice; complex surgery
Distal cholangiocarcinomaBile duct near the pancreasUsually treated with the Whipple procedure
Gallbladder cancerGallbladderStrongly linked to gallstones; sometimes found after gallbladder removal
Ampullary cancerAmpulla of Vater (where bile and pancreatic ducts open)Causes jaundice early, so often found at a more treatable stage
Liver metastasesCancer spread from bowel, breast or other organsColorectal liver metastases can be curable with surgery in selected patients

Can hepatobiliary and pancreatic cancer be cured?

HPB cancer can be cured in some patients, most often when the tumor is found before it has spread and can be completely removed with surgery, usually combined with chemotherapy.

  • Surgery is the main route to cure: Complete removal with clear margins (R0 resection) gives the best chance of long-term survival.
  • Only some tumors are removable at diagnosis: For pancreatic cancer, an estimated 15–20% of patients have a tumor that can be removed when first diagnosed.
  • Chemotherapy can change the picture: Treatment before surgery may make some borderline tumors removable.
  • Other curative options: Liver transplant or ablation may cure selected early liver cancers.
  • When cure is not possible: Modern treatment can often control the cancer, relieve symptoms and extend life.

Why are HPB cancers often diagnosed late?

HPB cancers are often diagnosed late because the liver, pancreas and bile ducts lie deep inside the abdomen, and early tumors usually cause no symptoms or only vague ones.

  • No routine screening for the general population: Screening is offered only to higher-risk groups (see Section 12).
  • Vague early symptoms: Indigestion, tiredness or back pain are easily attributed to other causes.
  • Liver reserve: The liver keeps working normally until a large part is affected.

Why should I see a specialist HPB surgeon and high-volume centre?

Research generally links complex pancreatic and liver surgery at high-volume centres with specialist HPB surgeons to lower complication and mortality rates.

  • Complex anatomy: HPB operations involve major blood vessels and delicate reconstructions.
  • Rescue from complications: Experienced teams with interventional radiology and critical care support are better able to manage complications if they occur.
  • Accurate resectability decisions: Specialist review can identify patients who may be offered surgery after being told their tumor is inoperable elsewhere.
  • Ask directly: β€œHow many Whipple procedures or liver resections does your team perform each year?”

2. Symptoms & Warning Signs

What are the early symptoms of pancreatic cancer?

Commonly reported symptoms of pancreatic cancer include painless jaundice, upper abdominal pain spreading to the back, unexplained weight loss and new-onset diabetes; early tumors often cause no symptoms, and many of these symptoms have non-cancer causes.

  • Yellowing of the skin and eyes (jaundice), often without pain
  • Dark urine, pale or clay-coloured stools and itchy skin
  • Dull pain in the upper abdomen or middle back, often worse after eating or lying down
  • Unexplained weight loss and loss of appetite
  • Oily, floating, foul-smelling stools (steatorrhea)
  • Diabetes appearing after age 50 without a family history or weight gain, or diabetes suddenly becoming hard to control
  • Nausea, vomiting or feeling full quickly
  • Blood clots in the legs or lungs without an obvious cause

What are the symptoms of liver cancer, bile duct cancer and gallbladder cancer?

Liver, bile duct and gallbladder cancers most often cause jaundice, pain in the upper right abdomen, weight loss and, in people with cirrhosis, a sudden worsening of liver function.

SymptomLiver Cancer (HCC)Bile Duct CancerGallbladder CancerPancreatic Cancer
JaundicePossibleVery commonCommonCommon (head of pancreas)
Itching, dark urine, pale stoolsPossibleVery commonCommonCommon
Right upper abdominal painCommonCommonVery commonLess common
Back painUncommonUncommonUncommonCommon
Lump or swelling in the abdomenPossibleUncommonPossibleUncommon
Fluid in the abdomen (ascites)CommonAdvanced diseaseAdvanced diseaseAdvanced disease
New or worsening diabetesUncommonUncommonUncommonPossible warning sign
Fever with chills (cholangitis)UncommonPossiblePossiblePossible
Weight loss and fatigueCommonCommonCommonVery common

Is jaundice always a sign of cancer?

Jaundice is not always caused by cancer; gallstones, hepatitis and other liver conditions are more common causes, but jaundice always needs prompt medical assessment.

  • Painless jaundice: Especially in people over 50, this needs urgent evaluation for a blockage in the bile duct or pancreas.
  • Jaundice with fever and chills: May indicate a bile duct infection (cholangitis), which needs same-day emergency care.
  • First tests: Blood tests (liver function) and an ultrasound, followed by CT or MRI if a blockage is found.

3. Causes, Risk Factors & Pre-Cancerous Conditions

What caused my liver, pancreatic or bile duct cancer?

HPB cancers usually develop from a combination of long-term inflammation, genetic changes and lifestyle or environmental factors, and in many patients no single cause can be identified.

Risk FactorCancers Most Linked
Chronic hepatitis B or C infectionLiver cancer (HCC), intrahepatic cholangiocarcinoma
Cirrhosis from any causeLiver cancer (HCC)
Fatty liver disease (MASLD/NASH), obesity, diabetesLiver cancer, pancreatic cancer
AlcoholLiver cancer, pancreatic cancer (via chronic pancreatitis)
Tobacco (smoking and chewing)Pancreatic cancer, bile duct cancer
Gallstones, especially large or long-standingGallbladder cancer
Chronic pancreatitisPancreatic cancer
Primary sclerosing cholangitis (PSC)Bile duct cancer, gallbladder cancer
Choledochal cysts; liver fluke infectionBile duct cancer
Aflatoxin (mould on poorly stored grains and nuts)Liver cancer
Inherited gene changes (BRCA2, PALB2, Lynch syndrome, others)Pancreatic and bile duct cancers
  • A risk factor is not a cause: Many people with these risk factors never develop cancer, and many patients have none.
  • Regional patterns: Gallbladder cancer is notably more common in parts of northern and north-eastern India, Chile and some other regions.

I have a pancreatic cyst. Is it cancer?

Most pancreatic cysts are not cancer, but some types, particularly mucinous cysts such as IPMN and MCN, can become cancerous over time and need specialist monitoring or surgery.

Cyst TypeCancer RiskUsual Approach
Pseudocyst (after pancreatitis)Not pre-cancerousObservation or drainage if symptomatic
Serous cystadenomaVery lowObservation; surgery only if large or causing symptoms
Branch-duct IPMNLow to moderateRegular MRI/EUS surveillance; surgery if high-risk features appear
Main-duct IPMNHighSurgery usually recommended if fit
Mucinous cystic neoplasm (MCN)ModerateSurgery often recommended
Solid pseudopapillary neoplasm (SPN)Low-grade malignant potentialSurgery usually recommended
  • Warning features: Cyst size of 3 cm or more, a solid component, a dilated main pancreatic duct, rapid growth or jaundice

Is pancreatic or bile duct cancer hereditary?

An estimated 5–10% of pancreatic cancers are linked to inherited gene changes, and international guidelines, including NCCN, recommend offering germline genetic testing to everyone diagnosed with pancreatic cancer.

  • Genes involved: BRCA1, BRCA2, PALB2, ATM, CDKN2A, Lynch syndrome genes and STK11
  • Why it matters for you: Some gene changes, such as BRCA, can influence the choice of chemotherapy and maintenance treatment.
  • Why it matters for your family: Relatives can be offered testing and, if appropriate, pancreatic surveillance.

4. Diagnosis, Tests & Biomarkers

What tests will I need to diagnose and stage HPB cancer?

HPB cancer is diagnosed and staged with high-quality cross-sectional imaging, blood tests and, in most cases, a biopsy, which together show the cancer type, its extent and whether it can be removed.

StepTestWhy It Is Done
1Liver function tests and blood countsAssess jaundice, liver health and fitness for treatment
2Triple-phase / pancreatic-protocol CT scanMain test for tumor size, blood vessel involvement and spread
3MRI with MRCPDetailed view of the liver, bile ducts and pancreatic duct
4Endoscopic ultrasound (EUS) with biopsyClose-up imaging of the pancreas and bile duct; tissue sampling
5ERCP with brushings or stentObtains cells from the bile duct and relieves jaundice when needed
6Tumor markers (CA 19-9, CEA, AFP)Support diagnosis, assess prognosis and monitor response
7PET-CT or Ga-68 DOTATATE PETLooks for hidden spread; DOTATATE PET for neuroendocrine tumors
8Staging laparoscopyChecks for small deposits on the abdominal lining before major surgery
9Biomarker and genetic testingIdentifies targets for precision treatment

How long do the tests take, and how do I prepare?

Most HPB diagnostic tests take under an hour, usually require a few hours of fasting, and report results within a few days to two weeks.

Table: Diagnostic test logistics for HPB cancer

TestTime NeededPreparationTypical Result Time
Pancreatic-protocol CT scan15–30 minutesFast about 4 hours; kidney function test for contrast1–2 days
MRI with MRCP30–60 minutesFast 4–6 hours; declare metal implants or pacemaker1–2 days
Endoscopic ultrasound (EUS)30–60 minutesFast 6–8 hours; review blood thinners; bring an escortFindings same day; biopsy 3–7 days
ERCP30–90 minutesFast 6–8 hours; blood clotting tests; usually a short hospital stayStent same day; brushings 3–7 days
PET-CT scan2–3 hours in totalFast about 6 hours; blood sugar check; avoid strenuous exercise1–2 days
Liver biopsy (image-guided)30–60 minutes plus 4–6 hours observationClotting tests; stop blood thinners as advised3–7 working days
Biomarker / genetic testingNot applicableUses biopsy tissue or a blood sample1–3 weeks

Typical timeframes only; always follow the instructions given for your appointment.

Do I always need a biopsy before surgery or treatment?

A biopsy is usually needed before chemotherapy or radiation, but some patients may proceed directly to surgery, or be diagnosed without a biopsy, when imaging findings are typical.

  • Liver cancer in cirrhosis: HCC can often be diagnosed on a high-quality CT or MRI (using LI-RADS criteria) without a biopsy.
  • Clearly resectable pancreatic tumors: Some centres proceed to surgery without a biopsy when imaging is highly suggestive and surgery is planned anyway.
  • Before chemotherapy first (neoadjuvant): A tissue diagnosis is required.
  • Bile duct cancer: Biopsies can be difficult; brushings, EUS and specialised tests may be combined.

My CA 19-9 is high. Does that mean I have pancreatic cancer?

A raised CA 19-9 does not by itself confirm pancreatic cancer, because it can also be raised by jaundice, bile duct blockage, pancreatitis and other conditions.

  • Most useful for: Tracking treatment response and detecting recurrence once cancer is diagnosed.
  • Jaundice effect: CA 19-9 is often re-checked after the bile duct is drained, because blockage can raise it falsely.
  • Not produced by everyone: An estimated 5–10% of people do not produce CA 19-9, so a normal level does not rule out cancer.

Will I need a stent to treat my jaundice before surgery?

Not every jaundiced patient needs a stent before surgery; biliary drainage is usually reserved for those with bile duct infection, severe itching, very high bilirubin, or who will receive chemotherapy or face a delay before surgery.

  • ERCP stent: Placed through an endoscope; the most common method.
  • P (percutaneous drainage): Placed through the skin into the liver when ERCP is not possible, often for perihilar tumors.
  • Metal vs plastic stents: Metal stents tend to stay open longer and are often preferred if chemotherapy is planned first.

Table: Biliary stent and drainage options at a glance

OptionHow It Is PlacedTypical Duration Before Review or ExchangeTypical Hospital Time
Plastic ERCP stentThrough an endoscope passed via the mouthOften exchanged about every 3 monthsDay procedure or overnight stay
Metal ERCP stent (SEMS)Through an endoscope passed via the mouthOften remains open for many monthsDay procedure or overnight stay
P drainThrough the skin into the liver under imaging guidanceWeeks to months; may be converted to an internal stent1–3 days
EUS-guided biliary drainageThrough an endoscope with ultrasound guidanceOften similar to a metal stent1–2 days

Stent lifespan varies from patient to patient. Fever, chills or returning jaundice may mean a blocked stent and need same-day review.

How long will it take from diagnosis to starting treatment?

For most patients, HPB cancer treatment begins within about two to four weeks of diagnosis, once staging is complete and the tumor board has agreed a plan.

Table: Typical patient journey from first visit to treatment

StageWhat HappensTypical Timeframe
First consultationHistory, examination, review of existing scans and reportsWeek 1
Diagnostic and staging testsCT/MRI, EUS or ERCP, biopsy, blood testsWeeks 1–2
Jaundice relief (if needed)Biliary stent or drainageWithin days, as needed
Tumor board reviewResectability and treatment plan agreedWeeks 2–3
Pre-treatment optimisationNutrition, fitness, diabetes and liver function assessmentWeeks 2–3
Treatment startSurgery, chemotherapy or liver-directed therapy beginsWeeks 2–4

Timelines vary with test availability and your health.

What biomarkers should my tumor be tested for?

Biomarker testing identifies molecular changes in HPB cancers that can make you eligible for targeted therapy, immunotherapy or clinical trials, and it is especially valuable in bile duct and pancreatic cancer.

BiomarkerRelevant CancersWhat It Can Mean for Treatment
BRCA1/2, PALB2 (germline)PancreaticMay predict platinum sensitivity; possible olaparib maintenance
KRAS (including G12C)PancreaticPresent in about 90%; KRAS G12C and KRAS wild-type tumors may have targeted options or trials
NTRK, NRG1, BRAF, RET fusions/mutationsPancreatic, biliaryRare but potentially targetable
FGFR2 fusionsIntrahepatic cholangiocarcinomaPossible eligibility for FGFR inhibitors (e.g., pemigatinib, futibatinib)
IDH1 mutationsIntrahepatic cholangiocarcinomaPossible eligibility for ivosidenib
HER2 amplificationGallbladder, bile ductPossible eligibility for HER2-directed therapy
MSI-H / dMMR, high TMBAll HPB cancersOften associated with strong responses to immunotherapy
Somatostatin receptor statusNeuroendocrine tumorsEligibility for somatostatin analogues and PRRT

Drug approvals and availability vary by country. Your oncologist will advise which options apply to you.

5. Staging, Resectability & Survival Rates

What stage is my cancer, and can it be removed with surgery?

For HPB cancers, the most practical question is resectability, meaning whether the tumor can be completely removed, which depends on its involvement of major blood vessels, spread and your liver function and fitness.

Pancreatic Cancer CategoryWhat It MeansUsual Treatment Approach
ResectableNo significant contact with major arteries or veins; no distant spreadSurgery, usually with chemotherapy before and/or after
Borderline resectableLimited contact with blood vessels that may be reconstructedChemotherapy (sometimes radiation) first, then surgery if the response is good
Locally advancedExtensive involvement of major arteries; no distant spreadChemotherapy Β± radiation; surgery reconsidered in selected responders
MetastaticSpread to the liver, lungs or abdominal liningSystemic therapy and supportive care

How is liver cancer (HCC) staged?

Liver cancer is most commonly staged using the Barcelona Clinic Liver Cancer (BCLC) system, which considers tumor burden, liver function and overall health to guide treatment.

BCLC StageDescriptionCommon Treatment Options
0 (very early)Single tumor under 2 cm; good liver functionResection or ablation
A (early)Single tumor, or up to 3 tumors each 3 cm or lessResection, ablation or liver transplant
B (intermediate)Multiple tumors in the liver; no vessel invasion or spreadTACE or TARE; transplant in selected cases; systemic therapy
C (advanced)Blood vessel invasion or spread outside the liverImmunotherapy combinations and targeted therapy
D (end stage)Severely reduced liver function or poor general healthSupportive care; transplant only if criteria are met

What is the survival rate for pancreatic, liver, bile duct and gallbladder cancer?

Survival rates for HPB cancers vary widely by cancer type and stage, and they are generally much higher when the cancer is found before it spreads and can be removed.

Cancer TypeLocalizedRegional SpreadDistant SpreadAll Stages
Gallbladder cancer~69%~28%~3%~20%
Pancreatic cancer~44%~16%~3%~13%
Liver cancer (incl. intrahepatic bile duct)~37%~13%~3%~22%
Intrahepatic bile duct cancer~23%~9%~3%~9%
Extrahepatic bile duct cancer~18%~17%~2%~11%

Approximate 5-year relative survival based on US SEER data as reported by the American Cancer Society. These figures describe past patients and cannot predict an individual outcome.

  • Surgery can change the outlook: Patients whose tumors are completely removed and who complete chemotherapy generally have better outcomes than the all-stage averages.
  • Treatment is improving: Many newer treatments were not available to the patients in these figures.
  • Personal estimate: Your oncologist can give a more tailored outlook once staging and biomarker results are available.

Can stage 4 pancreatic or liver cancer be treated?

Stage 4 pancreatic and liver cancer are generally not curable, but they are treatable, and chemotherapy, immunotherapy and targeted therapy can often slow the cancer, relieve symptoms and extend life.

  • Pancreatic cancer: FOLFIRINOX, NALIRIFOX or gemcitabine with nab-paclitaxel are common first-line options; olaparib maintenance may help BRCA carriers.
  • Liver cancer: Immunotherapy combinations such as atezolizumab with bevacizumab or durvalumab with tremelimumab improved survival compared with older treatments in clinical trials.
  • Bile duct and gallbladder cancer: Gemcitabine and cisplatin with durvalumab or pembrolizumab, plus targeted drugs for specific biomarkers.
  • Palliative care alongside treatment: Can improve quality of life at every stage.

6. Treatment Options & HPB Surgery

What are the treatment options for hepatobiliary and pancreatic cancer?

HPB cancer is treated with surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, liver-directed procedures and liver transplantation, often in combination and tailored by a multidisciplinary tumor board.

  • Surgery: Removes the tumor with surrounding tissue and lymph nodes; the main curative treatment.
  • Chemotherapy: Before surgery (neoadjuvant), after surgery (adjuvant) or as the main treatment for advanced disease.
  • Radiation therapy: Chemoradiation or SBRT for selected pancreatic, bile duct and liver tumors.
  • Immunotherapy: Particularly important in liver and biliary tract cancers.
  • Targeted therapy: Matched to biomarkers such as FGFR2, IDH1, HER2 or BRCA.
  • Ablation (RFA/MWA): Destroys small liver tumors with heat through a needle.
  • TACE and TARE (Y-90): Deliver chemotherapy or radiation directly to liver tumors through their blood supply.
  • Liver transplantation: For selected early liver cancers in patients with cirrhosis.
  • PRRT (e.g., Lutetium-177 dotatate): Targeted radionuclide therapy for suitable neuroendocrine tumors.
  • Endoscopic and interventional procedures: Stents and drainage to relieve jaundice or blockage.

What is the Whipple procedure, and what other operations are used for HPB cancer?

The Whipple procedure (pancreaticoduodenectomy) is the standard operation for cancers of the pancreatic head, ampulla and lower bile duct, and it is one of several specialised HPB operations chosen according to tumor location.

SurgeryUsed ForWhat Is Removed or Reconstructed
Whipple procedure / pylorus-preserving pancreaticoduodenectomyPancreatic head, ampullary, distal bile duct and some duodenal cancersHead of pancreas, duodenum, gallbladder and lower bile duct; pancreas, bile duct and stomach reconnected to the intestine
Distal pancreatectomyTumors in the body or tail of the pancreasBody and tail of pancreas, usually with the spleen
Total pancreatectomyTumors involving the whole pancreas or extensive IPMNEntire pancreas; lifelong insulin and enzyme replacement needed
Vascular resection and reconstructionTumors involving the portal or superior mesenteric veinAffected vein segment removed and repaired during pancreatic surgery
Minor or major hepatectomyLiver cancer, intrahepatic cholangiocarcinoma, liver metastasesSegments or a whole side (lobe) of the liver; the rest regrows
Bile duct resection with hepaticojejunostomyPerihilar cholangiocarcinomaBile ducts, often with part of the liver; bile ducts joined to the intestine
Radical (extended) cholecystectomyGallbladder cancerGallbladder, adjacent liver and regional lymph nodes
Liver transplantationSelected early HCC with cirrhosis; selected perihilar cholangiocarcinomaEntire diseased liver replaced with a donor liver

Is Whipple surgery safe? What are the risks?

The Whipple procedure is a major operation with a significant risk of complications, but at experienced high-volume centres the risk of death is generally low, and many complications can be managed without further surgery.

  • Complications are common: An estimated 30–50% of patients experience at least one complication, most of them manageable.
  • Mortality at experienced centres: Commonly reported below about 2–5%, and generally higher at low-volume hospitals.
  • Key to safety: Careful patient selection, pre-operative optimisation and an experienced team including interventional radiology and critical care.
  • Ask your surgeon: β€œWhat are your team’s complication and mortality rates for this operation?”

How should I prepare for pancreatic or liver surgery?

Preparing for HPB surgery over the two to four weeks beforehand, through exercise, nutrition and medication review, can help lower the risk of complications and speed up recovery.

Table: Preparation timeline before HPB surgery

WhenWhat to DoWhy It Helps
2–4 weeks beforeWalk daily; do breathing exercises; eat a high-protein diet; stop smoking and alcoholBuilds fitness and lowers the risk of lung and wound complications
1–2 weeks beforePre-anaesthesia check, blood tests and review of medicines, including blood thinners and diabetes medicinesReduces bleeding and anaesthesia risks
A few days beforeArrange support at home for after discharge; confirm admission timeMakes the return home smoother
Night beforeFollow fasting instructions; take a carbohydrate drink only if advisedSafe anaesthesia; supports faster recovery (ERAS)
Day of surgeryBring your medication list, reports, scans and IDEnsures your team has complete information

Always follow the specific instructions from your surgical and anaesthesia teams.

Will I have enough liver left after liver surgery?

The liver can regenerate, and surgeons can often remove a large portion of a healthy liver, provided enough functioning liver remains, usually at least 20–30% of a normal liver or around 40% in a liver damaged by cirrhosis or chemotherapy.

  • Pre-operative planning: CT volumetry measures how much liver will remain (the future liver remnant).
  • Portal vein embolization (PVE): Blocks blood flow to the side being removed so the remaining side grows larger before surgery.
  • Two-stage hepatectomy or ALPPS: Staged operations for selected patients with extensive disease.
  • Regrowth: The remaining liver typically regains much of its original volume within a few months.

Table: Typical timeline for portal vein embolization (PVE) before liver surgery

StepWhat HappensTypical Timing
CT volumetryMeasures how much liver will remain after surgeryDuring surgical planning
Portal vein embolizationA radiologist blocks the portal vein branch to the part of the liver to be removed, through a needleDay procedure or 1–2 night stay
Repeat CT volumetryChecks how much the remaining liver has grownAbout 3–6 weeks after PVE
Liver resectionSurgery goes ahead if the remaining liver has grown enoughOften 4–8 weeks after PVE

Am I a candidate for a liver transplant for liver cancer?

Liver transplantation may be an option for patients with early-stage liver cancer and cirrhosis who meet established criteria, such as the Milan criteria, because it removes both the cancer and the diseased liver.

  • Milan criteria: A single tumor 5 cm or smaller, or up to three tumors each 3 cm or smaller, with no blood vessel invasion or spread outside the liver.
  • Downstaging: Some patients beyond these criteria may become eligible after TACE, TARE or ablation shrinks the tumors.
  • Donor options: Deceased donor or living donor transplant, depending on the programme.
  • Assessment: Includes liver function, overall fitness, social support and freedom from alcohol.

Why do I need chemotherapy before or after pancreatic surgery?

Chemotherapy before or after pancreatic surgery treats microscopic cancer cells that surgery alone cannot remove, and clinical trials have shown that it improves survival compared with surgery alone.

  • After surgery (adjuvant): Modified FOLFIRINOX for fit patients, or gemcitabine with capecitabine, usually for about six months.
  • Before surgery (neoadjuvant): Increasingly used for borderline resectable tumors and considered for resectable tumors in some centres.
  • Bile duct and gallbladder cancer: Capecitabine after surgery is a common standard.
  • Timing: Adjuvant chemotherapy usually starts within about 8–12 weeks after surgery, once recovery allows.

How often is chemotherapy given for HPB cancer?

Chemotherapy and immunotherapy for HPB cancer are given in cycles, most commonly every two to four weeks, and curative courses typically last about six months.

Table: Common HPB cancer treatment schedules

RegimenUsed ForHow OftenTypical Course Length
Modified FOLFIRINOX (adjuvant)Pancreatic cancer after surgeryEvery 2 weeksAbout 6 months (12 cycles)
Gemcitabine + capecitabine (adjuvant)Pancreatic cancer after surgeryGemcitabine days 1, 8, 15; capecitabine days 1–21 of each 28-day cycleAbout 6 months
Capecitabine (adjuvant)Bile duct and gallbladder cancer after surgeryDays 1–14 of each 21-day cycleAbout 6 months (8 cycles)
Gemcitabine + nab-paclitaxelAdvanced pancreatic cancerDays 1, 8, 15 of each 28-day cycleContinued while effective and tolerated
Gemcitabine + cisplatin + durvalumabAdvanced biliary tract cancerDays 1 and 8 of each 21-day cycleUp to 8 cycles, then durvalumab every 4 weeks
Atezolizumab + bevacizumabAdvanced liver cancer (HCC)Every 3 weeksContinued while effective and tolerated
Lutetium-177 dotatate (PRRT)Somatostatin receptor-positive NETsEvery 8 weeksUsually 4 treatments

Examples only. Your regimen, doses and number of cycles will be individualised by your oncologist.

What immunotherapy and targeted therapy options exist for HPB cancer?

Immunotherapy and targeted therapy are now part of standard care for many advanced liver and biliary tract cancers, and for pancreatic cancers with specific biomarkers.

CancerImmunotherapy / Targeted Options (examples)
Liver cancer (HCC)Atezolizumab + bevacizumab; durvalumab + tremelimumab; lenvatinib; sorafenib; regorafenib and cabozantinib after progression
Biliary tract cancerDurvalumab or pembrolizumab with chemotherapy; FGFR2 inhibitors; ivosidenib (IDH1); HER2-directed therapy
Pancreatic adenocarcinomaOlaparib maintenance (germline BRCA); immunotherapy for MSI-H tumors; NTRK inhibitors for NTRK fusions
Pancreatic neuroendocrine tumorsSomatostatin analogues (octreotide, lanreotide); everolimus; sunitinib; PRRT

Drug approvals and availability vary by country.

What non-surgical treatments are available for liver tumors?

Liver-directed therapies treat tumors inside the liver without major surgery, and they are used when surgery is not suitable, to control disease, or to shrink tumors before transplant.

TreatmentHow It WorksTypically Used For
Radiofrequency / microwave ablationA needle heats and destroys the tumorSmall tumors, usually up to about 3 cm
TACE (chemoembolization)Chemotherapy injected into the tumor’s artery, then the artery is blockedIntermediate-stage HCC; bridge to transplant
TARE / Y-90 radioembolizationRadioactive microspheres delivered to the tumor through its arteryHCC, including some with portal vein involvement; liver metastases
SBRTHigh-precision radiation in 3–5 sessionsTumors unsuitable for ablation or surgery

Can cancer that has spread to the liver be treated with surgery?

In selected patients, cancer that has spread to the liver can be removed with surgery; liver metastases from colorectal cancer in particular are often treated this way, and a meaningful proportion of these patients achieve long-term survival.

  • Colorectal liver metastases: Resection, often combined with chemotherapy, offers a potential cure for suitable patients.
  • Neuroendocrine liver metastases: Surgery, ablation or liver-directed therapy may control disease for many years.
  • Other cancers: Liver surgery for metastases from breast, stomach or other cancers is considered on a case-by-case basis.

7. Surgical Risks, Side Effects & Complications

What complications can happen after pancreatic or liver surgery?

The most common complications after HPB surgery are pancreatic fistula, delayed stomach emptying, bile leak, infection and bleeding, and many can be treated with drains, medicines or minimally invasive procedures.

ComplicationWhat It IsHow It Is Usually Managed
Pancreatic fistula (leak)Pancreatic juice leaks from the join between pancreas and intestineSurgical drains; radiology-guided drainage; nutrition support
Delayed gastric emptyingThe stomach is slow to empty after a WhippleTemporary feeding tube or medicines; usually resolves in weeks
Bile leakBile escapes from the liver surface or bile duct joinDrainage; ERCP stent in some cases
Post-hepatectomy liver failureThe remaining liver struggles to functionIntensive support; prevention through careful planning
BleedingEarly or delayed bleeding from vesselsBlood transfusion; interventional radiology embolization; surgery if needed
Infection / abscessCollection of infected fluidAntibiotics and image-guided drainage
DiabetesReduced insulin production after pancreatic surgeryDiet, tablets or insulin as needed

How long will I stay in hospital after HPB surgery?

Hospital stay after HPB cancer surgery commonly ranges from about four to fourteen days, depending on the operation, the surgical approach and whether complications occur.

Table: Typical hospital stay and recovery after HPB procedures

ProcedureTypical Hospital StayReturn to Light ActivityTypical Return to Desk Work
Liver ablation (RFA/MWA)1–2 daysWithin 1 week1–2 weeks
TACE / TARE1–2 daysWithin 1 week1–2 weeks
Minor liver resection (laparoscopic)3–5 days2–3 weeks4–6 weeks
Major liver resection (open)6–10 days4–6 weeks2–3 months
Whipple procedure7–14 days4–6 weeks2–3 months
Distal pancreatectomy5–7 days3–4 weeks6–8 weeks
Radical cholecystectomy4–7 days2–4 weeks4–8 weeks
Liver transplantation2–3 weeks6–8 weeks3–6 months

Complications may lengthen these times.

What side effects should I expect from chemotherapy and immunotherapy?

Side effects from HPB cancer treatment are common but mostly temporary, and supportive medicines can prevent or reduce many of them.

Side EffectCommon WithHow It Is Managed
Nausea, vomitingFOLFIRINOX, cisplatinPreventive anti-nausea medicines
FatigueMost treatmentsGentle activity, rest, treating anemia
Low blood counts / infection riskFOLFIRINOX, gemcitabineRegular blood tests; growth factor injections
Tingling or numbness (neuropathy)Oxaliplatin, nab-paclitaxelDose adjustment; avoid cold exposure with oxaliplatin
DiarrheaFOLFIRINOX, capecitabineMedicines and hydration
Hand-foot syndromeCapecitabine, sorafenib, lenvatinibMoisturisers, dose adjustment
High blood pressure, bleeding riskBevacizumab, lenvatinibBlood pressure monitoring; endoscopy for varices before bevacizumab
Immune-related inflammationImmunotherapyEarly reporting; steroids when necessary

When should I call my care team or go to the emergency department?

Contact your care team immediately, or go to the nearest emergency department, if you develop fever, chills, new or worsening jaundice, severe abdominal pain, bleeding or breathing difficulty.

Table: When to seek help during HPB cancer treatment

SymptomWhat to DoUrgency
Fever of 38Β°C (100.4Β°F) or higher, or shiveringCall the 24-hour oncology helpline or go to the emergency departmentImmediately
Fever with jaundice (possible stent blockage or cholangitis)Go to the emergency departmentImmediately
Vomiting blood, black stools or bleeding from a drainGo to the emergency departmentImmediately
Severe or sudden abdominal painGo to the emergency departmentImmediately
Breathlessness or chest painCall emergency servicesImmediately
Returning yellow skin or eyes, dark urineCall your HPB teamSame day
Unable to keep fluids down for 24 hoursCall the oncology helplineSame day
Very high or very low blood sugar readingsCall your team or diabetes nurseSame day
Oily stools, bloating, weight lossMention to your dietitian or doctorNext visit or within a week

24-hour oncology helpline: +91 88840 09955. In a life-threatening emergency, call your local emergency number.

8. Diet, Digestion & Diabetes

What should I eat after the Whipple procedure or pancreatic surgery?

After pancreatic surgery, dietitians commonly recommend small, frequent, protein-rich meals taken with pancreatic enzyme capsules, because the pancreas may no longer produce enough enzymes to digest food.

  • Eat little and often: Five to six small meals and snacks a day.
  • Prioritise protein: Eggs, dal, paneer, curd, fish, chicken and lentils.
  • Do not avoid fat unnecessarily: With correctly dosed enzymes, many patients can eat a normal amount of fat; follow your dietitian’s advice.
  • If sugary foods make you unwell: Tell your dietitian; limiting very sugary foods and drinks may help.
  • Stay hydrated: Sip fluids through the day.
  • Monitor weight weekly: Report continued weight loss to your team.

What are pancreatic enzymes, and how should I take them?

Pancreatic enzyme replacement therapy (PERT) replaces the digestive enzymes your pancreas can no longer make, and it works only when taken with food.

  • Take the capsules with the first bite of every meal and snack that contains fat or protein.
  • For larger meals, your dietitian may advise splitting the dose (half at the start, half midway).
  • Swallow capsules whole; if you cannot, ask how to open them safely.
  • Report oily or floating stools, bloating or weight loss, as your dose may need adjusting.
  • Do not stop enzymes without advice, even when you feel well.

Will I become diabetic after pancreatic surgery?

Diabetes can develop or worsen after pancreatic surgery, particularly after removal of the body and tail or the whole pancreas, and it requires monitoring and treatment.

OperationDiabetes RiskTypical Management
Whipple procedureModerate; some patients develop new diabetesBlood sugar monitoring; tablets or insulin if needed
Distal pancreatectomyHigher, depending on how much pancreas is removedMonitoring; insulin in some patients
Total pancreatectomyCertain; lifelong insulin requiredInsulin and specialist diabetes education

What should I eat with liver cancer or after liver surgery?

A balanced, protein-rich diet supports liver recovery, and many patients with liver cancer do not need to restrict protein; your team will advise if you do.

  • Avoid alcohol completely.
  • Limit salt: Especially if you have fluid in the abdomen (ascites) or leg swelling.
  • Late-evening snack: A carbohydrate-and-protein snack at bedtime is often advised for people with cirrhosis.
  • Supplements and herbal remedies: Check with your team first, because some can damage the liver or interact with treatment.

9. Recovery, Follow-Up & Recurrence

What is the follow-up schedule after HPB cancer treatment?

Follow-up after HPB cancer treatment is most frequent in the first two years, when the risk of recurrence is highest, and usually includes clinical review, tumor markers and CT or MRI scans.

Table: Typical follow-up schedule after curative HPB cancer treatment

Time After TreatmentVisit FrequencyTypical Tests
Years 1–2Every 3–6 monthsClinical review; CA 19-9, CEA or AFP; CT or MRI scan
Years 3–5Every 6–12 monthsClinical review; tumor markers; imaging as indicated
After 5 yearsYearlyClinical review; diabetes, nutrition and vitamin checks
After liver transplantLifelong, per transplant programmeImmunosuppression levels; AFP and imaging for recurrence

What are the chances my cancer will come back?

Recurrence is a real risk after HPB cancer surgery, especially for pancreatic and bile duct cancers, and it depends on stage, lymph node involvement, surgical margins and response to chemotherapy.

  • Timing: When recurrence happens, it most often does so within the first two to three years.
  • Liver cancer: New tumors can develop in a cirrhotic liver, so lifelong surveillance is usually advised.
  • If cancer returns: Treatment options such as chemotherapy, ablation, radiation or, occasionally, further surgery may still be available.

How long does recovery take after major HPB surgery?

Many patients regain most of their energy within two to three months of major HPB surgery, although full recovery, especially after the Whipple procedure, can take longer.

  • Enhanced Recovery After Surgery (ERAS): Early walking, early eating and good pain control help many patients recover faster.
  • Prehabilitation: Exercise and nutrition before surgery can improve recovery.
  • Gradual return: Increase activity step by step with physiotherapy guidance.
  • Hospital stay: See the hospital stay table in Section 7.

What are the typical recovery milestones after Whipple or major liver surgery?

Recovery after major HPB surgery usually follows a predictable sequence, from walking on the first day to starting chemotherapy within about two to three months, although each patient progresses at their own pace.

Table: Typical recovery milestones after Whipple or major liver surgery

Time After SurgeryWhat Typically Happens
Day 1Sitting out of bed, sips of fluid and a short walk with support
Days 2–5Soft diet begins; drains and urinary catheter reviewed and often removed
Days 7–14Discharge home for many patients
Weeks 2–3First clinic visit; wound check; final pathology results discussed
Weeks 4–6Light daily activities; driving only when off strong painkillers and cleared by your team
Weeks 8–12Adjuvant chemotherapy often starts, if recommended
Months 2–3Return to desk work for many patients

Complications or slower recovery may extend these timeframes.

10. Palliative & Supportive Care

Does palliative care mean my doctors have given up?

Palliative care does not mean giving up; it is specialist medical care that relieves symptoms and improves quality of life at any stage of cancer, and it can be given alongside active treatment.

  • Pain control: Medicines and nerve blocks such as the EUS-guided celiac plexus block for pancreatic cancer pain
  • Symptom relief: Itching, nausea, poor appetite, fatigue and breathlessness
  • Emotional and family support: Counselling and spiritual care
  • Planning ahead: Help with difficult decisions and advance care planning

How are jaundice, itching and blockages relieved in advanced HPB cancer?

Jaundice, itching and bowel blockage in advanced HPB cancer can often be relieved with minimally invasive stents, drainage or bypass procedures.

ProblemTreatment Options
Jaundice from bile duct blockageERCP metal stent; percutaneous biliary drainage (P); EUS-guided biliary drainage
Severe itchingRelieving the blockage; medicines such as cholestyramine or rifampicin
Blockage of the stomach outlet or duodenumDuodenal stent; EUS-guided gastrojejunostomy; surgical bypass
Fluid in the abdomen (ascites)Paracentesis; indwelling drainage catheter; diuretics
Pancreatic cancer painPain medicines; celiac plexus block or neurolysis; radiation
Bleeding from a tumorEndoscopic therapy; embolization; radiation

11. Second Opinions, Clinical Trials & Practical Questions

I was told my pancreatic or liver cancer is inoperable. Should I get a second opinion?

A second opinion from a specialist HPB team can be worthwhile when surgery has been ruled out, because resectability assessments can differ between centres, and some patients may become eligible for surgery after further review or chemotherapy.

  • Most oncologists support second opinions: It is a common and accepted part of cancer care.
  • Timing: A second opinion can usually be arranged without significantly delaying treatment.
  • What to bring: See the checklist below.

What documents should I bring to my HPB consultation?

Bring every scan, report and biopsy sample related to your diagnosis, because HPB decisions depend heavily on detailed review of the original images.

Table: Documents checklist for your HPB cancer consultation

ItemWhy It Is NeededFormat
CT and MRI scan imagesOur radiologists and surgeons review blood vessel involvement directlyImages on CD/DVD or online link (not only reports)
Biopsy, cytology or brushing reportsConfirms diagnosis; allows biomarker testingReports, plus slides and blocks from the lab
EUS and ERCP reportsShows tumor details and any stent placedPrinted reports with stent type and date
Blood tests (LFTs, CA 19-9, AFP, CEA)Liver function and tumor marker trendsAll available results, with dates
Hepatitis and cirrhosis recordsLiver function affects treatment choicesReports from your hepatologist
Medication listBlood thinners, diabetes medicines and interactionsNames, doses and timing
Previous treatment summariesShows chemotherapy or procedures already doneDischarge and treatment summaries
ID and insurance documentsNeeded for registration and approvalsGovernment ID; insurance card or policy

Am I eligible for a clinical trial?

Clinical trials give eligible patients access to promising new treatments under close monitoring, and they are especially important in pancreatic and bile duct cancer, where new therapies are actively being developed.

  • Ask early: Some trials require that you have not yet started treatment.
  • Biomarker results help: Many trials are matched to specific gene changes.
  • Voluntary: Taking part is always your choice, and you can withdraw at any time.

What questions should I ask my HPB oncologist or surgeon?

The most useful questions cover your exact diagnosis, whether the tumor can be removed, the goal of treatment, the risks of surgery and your team’s experience.

  • What type of HPB cancer do I have, and what stage is it?
  • Is my tumor resectable, borderline or not resectable, and why?
  • Is the goal of treatment cure or control?
  • Should I have chemotherapy before surgery?
  • How many of these operations does your team perform each year, and what are your complication rates?
  • Has my tumor been tested for biomarkers, and should I have genetic testing?
  • Will I need a stent for jaundice, and what type?
  • How will surgery affect my digestion and blood sugar?
  • Am I eligible for any clinical trials?
  • Who should I contact in an emergency, day or night?

How can I cope emotionally with an HPB cancer diagnosis?

Feeling shock, fear or sadness after an HPB cancer diagnosis is normal, and professional emotional support is an important part of cancer care.

  • Professional help: Speak with a psycho-oncologist or counsellor.
  • Peer support: Join a pancreatic or liver cancer support group.
  • Involve family: Bring a trusted person to consultations.
  • One step at a time: Focus on the next test or appointment rather than the whole journey.

12. Prevention & Screening

Can liver, pancreatic and gallbladder cancer be prevented?

Not every HPB cancer can be prevented, but the risk of many can be lowered by preventing and treating hepatitis, protecting liver health, avoiding tobacco and managing gallstone disease appropriately.

  • Hepatitis B vaccination: Recommended by the WHO for all infants, and advised for unvaccinated adults at risk.
  • Treat hepatitis B and C: Antiviral treatment can lower the risk of liver cancer.
  • Protect your liver: Limit alcohol, maintain a healthy weight and manage diabetes and fatty liver disease.
  • Avoid tobacco in all forms.
  • Store grains and nuts dry: Helps reduce exposure to aflatoxin.

Should I have my gallbladder removed if I have gallstones?

Most people with gallstones that cause no symptoms do not need surgery, but gallbladder removal (cholecystectomy) is generally advised for symptomatic gallstones and for certain findings linked to higher cancer risk.

  • Symptoms: Recurrent biliary pain, cholecystitis or pancreatitis caused by stones
  • Gallbladder polyps of 10 mm or more: Or smaller polyps that are growing
  • Porcelain (calcified) gallbladder
  • Very large stones: Stones of 3 cm or more may be considered for surgery, particularly in high-incidence regions
  • After removal: The gallbladder is sent for pathology; if cancer is found incidentally, specialist HPB review is recommended.

Who should be screened for liver or pancreatic cancer?

Surveillance is generally recommended for people at higher risk, including those with cirrhosis, chronic hepatitis B, high-risk pancreatic cysts or inherited gene changes linked to pancreatic cancer.

Table: Surveillance recommendations for high-risk groups

High-Risk GroupRecommended SurveillanceTypical Interval
Cirrhosis from any causeLiver ultrasound, with or without AFPEvery 6 months
Chronic hepatitis B (certain groups, even without cirrhosis)Liver ultrasound, with or without AFPEvery 6 months
Branch-duct IPMN or other mucinous cystMRI/MRCP and/or EUSEvery 6–24 months, depending on size and features
BRCA2, PALB2, CDKN2A, Lynch or strong family history of pancreatic cancerPancreatic MRI and/or EUS in expert centresUsually yearly
Primary sclerosing cholangitis (PSC)MRI/MRCP and CA 19-9; gallbladder ultrasoundUsually every 6–12 months
Gallbladder polyps under 10 mmUltrasoundPer specialist advice, often at 6 months, 1 year and 2 years

Book a Consultation with Our HPB Cancer Specialists

If you or a loved one has been diagnosed with, or is being tested for, liver, pancreatic, bile duct or gallbladder cancer, our HPB team can guide you through diagnosis, treatment, recovery and beyond.

  • Call: +91 88840 09955
  • Book online: /contact/
  • Second opinion and scan review requests: /contact/

Sources & Medical Review

  • National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines: Pancreatic Adenocarcinoma, Hepatocellular Carcinoma, Biliary Tract Cancers and Neuroendocrine Tumors
  • European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for HPB cancers
  • Barcelona Clinic Liver Cancer (BCLC) staging and treatment strategy
  • American Cancer Society / National Cancer Institute SEER survival statistics
  • International consensus guidelines for the management of pancreatic cystic neoplasms

Medical disclaimer: This information is for general education and does not replace personalised medical advice. Please consult a qualified oncologist or HPB surgeon about your specific diagnosis and treatment.

Medical review and sources

Medically reviewed by Dr Ashwin K.R. Β· Last reviewed: 10 October 2026

  • National Comprehensive Cancer Network (NCCN) Guidelines: Hepatocellular Carcinoma, Biliary Tract Cancers and Pancreatic Adenocarcinoma
  • European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for pancreatic and hepatocellular cancer

Medical disclaimer: This information is for general education and does not replace personalised medical advice. Please consult a qualified doctor about your specific diagnosis and treatment.